Skip to main content

Animations

MJFF Publications

1111 - 1120 of 6568 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • Summary Details
    OPEN
    Title: Cognitive Decline in Parkinson’s Disease: A Subgroup of Extreme Decliners Revealed by a Data-Driven Analysis of Longitudinal Progression
    Journal Name: Frontiers in Psychology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fpsyg.2021.729755
    Citation Count: 12
  • Summary Details
    OPEN
    Title: A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.69795
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.28596
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Altered Brain Functional Network in Subtypes of Parkinson's Disease: A Dynamic Perspective
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2021.710735
    Citation Count: 31
  • Summary Details
    OPEN
    Title: The PET tracer [ 11 C]MODAG-005 targets alpha-synuclein aggregates in the brain
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aec0813
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Parkinson's disease drug therapies in the clinical trial pipeline: 2015–2024
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x261454154
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Construct optimization for AAV-mediated human α-syn overexpression, and validation across research settings: Development of a shared tool for the research community
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/1877718x261447105
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Inter-assay and Inter-site Performance of Alpha-Synuclein Seed Amplification Assays in Synucleinopathies: A Multicenter 2 × 2 Protocol Comparison
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-026-00965-5
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The GBA1 p. E427K (p. E388K ) Variant Is a Risk Factor for Synucleinopathies: A Meta‐Analysis
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.70367
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Progressive Supranuclear Palsy in India: Insights from a Large Multicenter Clinical Cohort (Project PAIR ‐ PSP )
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.70672
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.